Search research articles
Contact Us
Filters
Showing results (811-820 of 875) with videos related to
Page
of 88
Sort By:
Cancer
|
October 24, 2022
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma
Rodrigo R Munhoz, Guilherme Nader-Marta, Veridiana P de Camargo, et al.
Pediatric Obesity
|
October 17, 2025
First 1000 Days Strategies to Prevent Childhood Obesity: A Narrative Review and Recommendations From the EndObesity Consortium
Mireille C Schipper, Anna Manshanden, Kaat Philippe, et al.
NPJ Digital Medicine
|
March 14, 2025
Holistic AI analysis of hybrid cardiac perfusion images for mortality prediction
Anna M Marcinkiewicz, Wenhao Zhang, Aakash Shanbhag, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 6, 2016
Design and optimization of (3-aryl-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-ones as potent PLK4 inhibitors with oral antitumor efficacy
Sze-Wan Li, Yong Liu, Peter B Sampson, et al.
The Journal of Antimicrobial Chemotherapy
|
September 30, 2017
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis
Marco Ripa, Olga Rodríguez-Núñez, Celia Cardozo, et al.
Developmental Cell
|
October 31, 2024
Combinatorial transcription factor binding encodes cis-regulatory wiring of mouse forebrain GABAergic neurogenesis
Rinaldo Catta-Preta, Susan Lindtner, Athena Ypsilanti, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2016
Discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as novel, highly potent and selective, orally bioavailable inhibitors of Tyrosine Threonine Kinase, TTK
Radoslaw Laufer, Sze-Wan Li, Yong Liu, et al.
Plos Biology
|
August 15, 2022
Analytical framework to evaluate and optimize the use of imperfect diagnostics to inform outbreak response: Application to the 2017 plague epidemic in Madagascar
Quirine Ten Bosch, Voahangy Andrianaivoarimanana, Beza Ramasindrazana, et al.
Journal of Medicinal Chemistry
|
July 9, 2013
The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agents
Radoslaw Laufer, Bryan Forrest, Sze-Wan Li, et al.
Elife
|
October 4, 2021
Parallel functional testing identifies enhancers active in early postnatal mouse brain
Jason T Lambert, Linda Su-Feher, Karol Cichewicz, et al.
Page
of 88
Search research articles
Search
Showing results (811-820 of 875) with videos related to
Sort By:
Page
of 88
Cancer
|
October 24, 2022
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma
Rodrigo R Munhoz, Guilherme Nader-Marta, Veridiana P de Camargo, et al.
Pediatric Obesity
|
October 17, 2025
First 1000 Days Strategies to Prevent Childhood Obesity: A Narrative Review and Recommendations From the EndObesity Consortium
Mireille C Schipper, Anna Manshanden, Kaat Philippe, et al.
NPJ Digital Medicine
|
March 14, 2025
Holistic AI analysis of hybrid cardiac perfusion images for mortality prediction
Anna M Marcinkiewicz, Wenhao Zhang, Aakash Shanbhag, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 6, 2016
Design and optimization of (3-aryl-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-ones as potent PLK4 inhibitors with oral antitumor efficacy
Sze-Wan Li, Yong Liu, Peter B Sampson, et al.
The Journal of Antimicrobial Chemotherapy
|
September 30, 2017
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis
Marco Ripa, Olga Rodríguez-Núñez, Celia Cardozo, et al.
Developmental Cell
|
October 31, 2024
Combinatorial transcription factor binding encodes cis-regulatory wiring of mouse forebrain GABAergic neurogenesis
Rinaldo Catta-Preta, Susan Lindtner, Athena Ypsilanti, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2016
Discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as novel, highly potent and selective, orally bioavailable inhibitors of Tyrosine Threonine Kinase, TTK
Radoslaw Laufer, Sze-Wan Li, Yong Liu, et al.
Plos Biology
|
August 15, 2022
Analytical framework to evaluate and optimize the use of imperfect diagnostics to inform outbreak response: Application to the 2017 plague epidemic in Madagascar
Quirine Ten Bosch, Voahangy Andrianaivoarimanana, Beza Ramasindrazana, et al.
Journal of Medicinal Chemistry
|
July 9, 2013
The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agents
Radoslaw Laufer, Bryan Forrest, Sze-Wan Li, et al.
Elife
|
October 4, 2021
Parallel functional testing identifies enhancers active in early postnatal mouse brain
Jason T Lambert, Linda Su-Feher, Karol Cichewicz, et al.
Page
of 88